This webinar provides a background and overview of the issues and many years-long discussions in antibacterial drug development for hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP).
Meeting Objectives
This webinar served to familiarize the diverse group of participating experts with detailed information on this research topic as a preamble to the HABP/VABP pilot study protocol workshop that occurred in Bethesda on April 22 - 23, 2013.